Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroprotective Effects of Sorghum Polyphenol in Alzheimer's Disease: In Vitro and In Silico Analyses.

Nutrients·2026
Same author

Nutritional Strategies Targeting Glucose Metabolism to Slow Cognitive Ageing: A Scoping Review of Human Trials.

The American journal of clinical nutrition·2026
Same author

Cognitive decline in Dutch-type hereditary and sporadic cerebral amyloid angiopathy: a 5-year follow-up study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Impact of plasma pTau181 levels on clinician diagnostic confidence and management in memory and cognition clinics: A multi-site before-and-after study.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Translational Feasibility of Curcumin for Treatment of Alzheimer's Disease: A Critical Appraisal of Clinical Challenges.

Antioxidants (Basel, Switzerland)·2026
Same author

Stage-dependent dynamics of neuroinflammation across the Alzheimer's continuum.

Brain, behavior, and immunity·2026

Related Experiment Video

Updated: May 10, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Multiplex biomarkers in blood.

Veer Bala Gupta1, Ramani Sundaram2, Ralph N Martins3

  • 1Centre of Excellence for Alzheimer's disease Research & Care, School of Medical Sciences, Edith Cowan University, Joondalup, WA, 6027 Australia.

Alzheimer'S Research & Therapy
|June 26, 2013
PubMed
Summary

Developing multiplex blood biomarker panels shows promise for early Alzheimer's disease detection. Standardization challenges persist due to population, sample, and method variations globally.

More Related Videos

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test
05:25

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Published on: July 14, 2023

Multiplexed Barcoding Image Analysis for Immunoprofiling and Spatial Mapping Characterization in the Single-Cell Analysis of Paraffin Tissue Samples
08:18

Multiplexed Barcoding Image Analysis for Immunoprofiling and Spatial Mapping Characterization in the Single-Cell Analysis of Paraffin Tissue Samples

Published on: April 7, 2023

Related Experiment Videos

Last Updated: May 10, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test
05:25

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Published on: July 14, 2023

Multiplexed Barcoding Image Analysis for Immunoprofiling and Spatial Mapping Characterization in the Single-Cell Analysis of Paraffin Tissue Samples
08:18

Multiplexed Barcoding Image Analysis for Immunoprofiling and Spatial Mapping Characterization in the Single-Cell Analysis of Paraffin Tissue Samples

Published on: April 7, 2023

Area of Science:

  • Neuroscience
  • Biomarker Discovery
  • Alzheimer's Disease Research

Background:

  • Early identification of Alzheimer's disease (AD) is crucial for effective intervention before irreversible neurodegeneration.
  • Current diagnostic methods often identify AD at later stages, limiting treatment efficacy.
  • Blood biomarkers offer a minimally invasive approach for preclinical AD detection.

Purpose of the Study:

  • To review recent and current approaches in blood biomarker discovery for Alzheimer's disease.
  • To highlight the challenges and need for standardized multiplex biomarker panels.
  • To discuss issues affecting reproducibility in blood biomarker research for AD.

Main Methods:

  • Literature review of past and current research in blood biomarker discovery for Alzheimer's disease.
  • Analysis of the limitations of individual blood biomarkers.
  • Discussion of the potential and challenges of multiplex biomarker panels.

Main Results:

  • Individual blood biomarkers have proven insufficient for accurate AD diagnosis, pathology definition, and progression tracking.
  • Multiplex panels of blood biomarkers are emerging as a promising strategy for sensitive and specific early AD diagnosis.
  • Significant challenges exist in standardizing global blood biomarker panels due to variations in populations, samples, and methodologies.

Conclusions:

  • A multiplex panel approach is essential for accurate and sensitive early Alzheimer's disease detection.
  • Standardization of methodologies and consideration of population differences are critical for developing a reliable global biomarker panel.
  • Addressing issues of reproducibility is key to advancing blood biomarker research for Alzheimer's disease.